<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJST</journal-id><journal-title-group><journal-title>Open Journal of Stomatology</journal-title></journal-title-group><issn pub-type="epub">2160-8709</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojst.2018.83008</article-id><article-id pub-id-type="publisher-id">OJST-83133</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Primary Neuroendocrine Carcinoma Combined with Squamous Cell Carcinoma of the Soft Palate: A Case Report and Review of Literature
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chatchaphan</surname><given-names>Udompatanakorn</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Naomi</surname><given-names>Yada</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ayataka</surname><given-names>Ishikawa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ikuya</surname><given-names>Miyamoto</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yukiko</surname><given-names>Sato</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kou</surname><given-names>Matsuo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Oral and Maxillofacial Reconstructive Surgery, School of Dentistry, Iwate Medical University, Morioka, Japan</addr-line></aff><aff id="aff4"><addr-line>Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan</addr-line></aff><aff id="aff2"><addr-line>Department of Pathology, Saitama Cancer Center, Saitama, Japan</addr-line></aff><aff id="aff1"><addr-line>Division of Oral Pathology, Department of Health Promotion, Kyushu Dental University, Kitakyushu, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>r12yada@fa.kyu-dent.ac.jp(NY)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>03</month><year>2018</year></pub-date><volume>08</volume><issue>03</issue><fpage>90</fpage><lpage>99</lpage><history><date date-type="received"><day>13,</day>	<month>February</month>	<year>2018</year></date><date date-type="rev-recd"><day>17,</day>	<month>March</month>	<year>2018</year>	</date><date date-type="accepted"><day>20,</day>	<month>March</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b> Neuroendocrine carcinomas (NECs) are rare neoplasms that widely occur in various organs. They are heterogeneous and vary from low to high grade malignant. NEC presenting with a squamous cell carcinoma (SCC) component is referred to as a composite tumor. Thus far, few cases of this composite tumor in the oral cavity have been reported in the literature; thus, the histogenesis remains unclear. 
  <b>ase Presentation:</b> We encountered a rare case of a primary NEC combined with SCC, occurring at the soft palate in a 59-year-old man. A resected specimen of the tumor was composed of two components: NEC and SCC. The NEC area contained small round to oval atypical cells arranged in nests with a glandular-like-pattern, hyperchromatic molded nuclei, a high nuclear-to-cytoplasmic ratio, and a scant eosinophilic cytoplasm. The SCC area was composed of non-keratotic, dysplastic oval to spindle-shaped squamous cells with indistinct cell borders and large nuclei that were hyperchromatic and pleomorphic. Immunohistochemically, the tumor cells of the NEC component were positive for chromagranin A, synaptophysin, CD56, and p16, whereas those of the SCC component were positive for 34
  βE12, p63, and p16. 
  <b>Conclusion:</b> In consideration of the morphological and immunohistochemical results, the final diagnosis was a primary NEC combined with SCC of the soft palate.
 
</p></abstract><kwd-group><kwd>Oral Cavity</kwd><kwd> Neuroendocrine Carcinoma</kwd><kwd> Squamous Cell Carcinoma</kwd><kwd> Combined Tumor</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Neuroendocrine carcinomas (NECs) are classified as a subgroup of neuroectodermal neoplasms with epithelial differentiation, which are heterogeneous and vary from low to high grade malignant. They can widely occur in different organs, particularly the lungs and larynx [<xref ref-type="bibr" rid="scirp.83133-ref1">1</xref>] . According to the World Health Organization (2017), NECs of the larynx are classified as well, moderately, and poorly differentiated types [<xref ref-type="bibr" rid="scirp.83133-ref2">2</xref>] . Two subtypes of poorly differentiated NECs are recognized as small cell and large cell NEC [<xref ref-type="bibr" rid="scirp.83133-ref2">2</xref>] . Most NECs of the head and neck region occur in the larynx and salivary glands. The oral cavity is an unfrequent location of primary NECs [<xref ref-type="bibr" rid="scirp.83133-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref4">4</xref>] . Interestingly, an NEC combined with a squamous cell carcinoma (SCC) component is referred to as a composite tumor [<xref ref-type="bibr" rid="scirp.83133-ref5">5</xref>] . To the best of our knowledge, there have only been three cases of NEC combined with SCC in the oral cavity reported to date [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref8">8</xref>] . Although some cases of NEC and SCC overlap have been reported, the possible role of neuroendocrine differentiation in head and neck SCC remains unclear [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>] . In this report, we describe a rare case of a primary NEC combined with SCC of the soft palate, and discuss the etiology as well as the histopathological and immunohistochemical features of the tumor.</p></sec><sec id="s2"><title>2. Case Presentation</title><p>A 59-year-old Japanese man, with a history of smoking, presented to our hospital with a chief complaint of a painful mass of the right side of the soft palate that first appeared 2 months beforehand. An intraoral examination revealed an irregular reddish mass, measuring approximately 5 &#215; 4 cm (<xref ref-type="fig" rid="fig1">Figure 1</xref>). An incisional biopsy was performed, which resulted in a diagnosis of cT2N0M0 SCC. Hence, tumorectomy of the soft palate to the mesopharynx was performed along with neck dissection and flap reconstruction using the forearm skin. There was no evidence of disease at 30 months after surgery.</p></sec><sec id="s3"><title>3. Pathological Findings</title><p>Microscopically, the resected specimen consisted of two components (<xref ref-type="fig" rid="fig2">Figure 2</xref>(A) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(B)). One of the components was composed of solid nests,</p><p>cords, and glandular-like structures with dispersed high mitotic activities (<xref ref-type="fig" rid="fig2">Figure 2</xref>(C)), in addition to small round to oval atypical cells with hyperchromatic molded nuclei, high nuclear-to-cytoplasmic ratios, inconspicuous nucleoli, and scant eosinophilic cytoplasm, as well as oval-shaped cells with abundant cytoplasm (<xref ref-type="fig" rid="fig2">Figure 2</xref>(D)). The histologic differential diagnosis of the first component included poorly differentiated SCC, basaloid SCC (BSCC), adenosquamous carcinoma, and NEC. The other component consisted of two phenotypic morphologies. The major area was non-keratotic consisting of dysplastic oval to spindle-shaped squamous cells with indistinct cell borders (<xref ref-type="fig" rid="fig2">Figure 2</xref>(E)) and large nuclei that were hyperchromatic and pleomorphic (<xref ref-type="fig" rid="fig2">Figure 2</xref>(F)). A few nests were composed of small and crowded basaloid cells. Nuclear palisading was observed at the periphery of the nests (<xref ref-type="fig" rid="fig2">Figure 2</xref>(G) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(H)). There was no metastasis to the neck lymph nodes.</p><p>The two components clearly showed different immunostaining patterns. Nest of atypical small cells were positive for neuroendocrine markers chromogranin A (<xref ref-type="fig" rid="fig3">Figure 3</xref>(A)), synaptophysin (<xref ref-type="fig" rid="fig3">Figure 3</xref>(B)), CD56 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(C)), and p16 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(D)), but negative for 34βE12 and p63. Areas of differentiated squamous cells and a few basaloid nests were positive for 34βE12 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(E)), p63 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(F)), and p16 (<xref ref-type="fig" rid="fig3">Figure 3</xref>(G)), but negative for all neuroendocrine markers. Both tumor components were negative for carcinoembryonic antigen (CEA). The immunohistochemical analysis results of the tumor components are summarized in <xref ref-type="table" rid="table1">Table 1</xref>. Based on these histological and immunohistochemical features, the final diagnosis was primary NEC combined with SCC of the soft palate.</p></sec><sec id="s4"><title>4. Discussion</title><p>NECs constitute a heterogeneous group of neoplasms with a wide range of tissue origins, histomorphological features, and clinical symptoms [<xref ref-type="bibr" rid="scirp.83133-ref4">4</xref>] . In addition, Mahomed et al. attempted to classify oral NECs into typical carcinoid, atypical carcinoid, small cell, and large cell types [<xref ref-type="bibr" rid="scirp.83133-ref9">9</xref>] . Epidemiologically, laryngeal NECs usually occur twice as common in males than in females and have been reported in patients in the sixth to seventh decade of life [<xref ref-type="bibr" rid="scirp.83133-ref10">10</xref>] . Most patients are heavy tobacco users [<xref ref-type="bibr" rid="scirp.83133-ref10">10</xref>] . Most NECs in the head and neck region occur in the larynx and salivary glands. The oral cavity is a rare site for primary NECs, which have been reported in only 15 cases to date [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref11">11</xref>] - [<xref ref-type="bibr" rid="scirp.83133-ref19">19</xref>] . The clinicopathological features of the reported cases of primary neuroendocrine tumor of the oral cavity are summarized in <xref ref-type="table" rid="table2">Table 2</xref>. The sites of primary NECs in the oral cavity were the gingiva, tongue, retromolar region, uvula, floor of the mouth, mandible, and buccal mucosa. The prognosis of oral NECs varies from no evidence of disease at follow-up, to local recurrence and distant metastasis [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>] . Some researchers have reported composite tumors of NEC and SCC in various locations, including the lungs and larynx [<xref ref-type="bibr" rid="scirp.83133-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref20">20</xref>] . To the best of our knowledge, there have only been three cases of NEC combined with SCC in the oral cavity</p><p>reported to date, which were located at the floor of the mouth and gingiva [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref8">8</xref>] .</p><p>The true origin and histogenesis of oral NECs are not clearly understood. Some researchers have proposed that NECs originate from neuroendocrine cells located at the basal layer of the oral squamous epithelium [<xref ref-type="bibr" rid="scirp.83133-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref21">21</xref>] . Another</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Summary of the immunohistochemical analysis results of the tumor components</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Marker</th><th align="center" valign="middle" >Atypical small cells</th><th align="center" valign="middle" >Squamous component and a few basaloid nests</th></tr></thead><tr><td align="center" valign="middle" >34βE12</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >p63</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >chromogranin A</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >synaptophysin</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >CD56</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >CEA</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >p16</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr></tbody></table></table-wrap><p>hypothesis is that NECs are derived from primitive and pluripotent indifferent cells of either the squamous epithelium or minor salivary gland [<xref ref-type="bibr" rid="scirp.83133-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref21">21</xref>] . NEC and SCC might arise from pluripotent cells that differentiated along two distinct pathways, or NEC could have differentiated secondarily from cells arising from a SCC [<xref ref-type="bibr" rid="scirp.83133-ref22">22</xref>] .</p><p>The differential diagnosis of basaloid-like carcinomas of the head and neck included BSCC, high-grade NEC, and poorly differentiated SCC. Differential diagnosis between these carcinoma types can be difficult by simple hematoxylin and eosin staining, especially when dealing with small biopsy specimens. Immunohistochemical staining provides more specific tissue antigen and tissue origin results. High molecular weight cytokeratins, such as 34βE12 and cytokeratin-5/6, can efficiently distinguish NECs from SCCs and BSCCs. Staining of SCCs and BSCCs is strongly positive for 34βE12, while NECs are negative [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref23">23</xref>] . p63 is also useful to identify basal and stem cells of the squamous epithelium and could be helpful to differentiate NECs from SCCs and BSCCs, as staining is positive for SCCs and BSCCs, but negative for NECs [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref23">23</xref>] . In our case, tumor cells of the squamous cell differentiated area and a few basaloid nests were positive for 34βE12 and p63, but negative for the neuroendocrine markers. Immunohistochemical analysis of NECs is usually positive for at least one neuroendocrine marker (chromogranin, synaptophysin, or CD56) [<xref ref-type="bibr" rid="scirp.83133-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.83133-ref23">23</xref>] . In our case, nests of atypical small cells were positive all of neuroendocrine markers (chromogranin A, synaptophysin, or CD56), while negative for high molecular weight cytokeratin 34βE12 and p63. Therefore, the final diagnosis of the present case, according to the histological and immunohistochemical features, was primary NEC combined with SCC. Adenosquamous carcinoma was excluded due to the lack of CEA immunoreactivity [<xref ref-type="bibr" rid="scirp.83133-ref24">24</xref>] . The possibility that the current tumor was a metastatic NEC was not favored, as an extensive clinical investigation failed to detect a primary tumor site.</p><p>In addition, recently, El-Mofty et al. [<xref ref-type="bibr" rid="scirp.83133-ref25">25</xref>] reported that human papillomavirus (HPV)-related oropharyngeal SCC had unique microscopic features due to the lack of keratinization and the presence of tumor cells containing bizarre nuclei</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Summary of clinicopathological features of the reported cases of primary neuroendocrine tumor of the oral cavity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Age/sex</th><th align="center" valign="middle" >Site</th><th align="center" valign="middle" >Smoking history</th><th align="center" valign="middle" >Histology</th><th align="center" valign="middle" >Cell size of NEC</th><th align="center" valign="middle" >IHC of NEC</th><th align="center" valign="middle" >IHC of SCC</th><th align="center" valign="middle" >Follow-up</th><th align="center" valign="middle" >Reference</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >63/M</td><td align="center" valign="middle" >Retromolar</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >DOD at 24 mths</td><td align="center" valign="middle" >Benning, et al. 1990 [<xref ref-type="bibr" rid="scirp.83133-ref11">11</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >76/M</td><td align="center" valign="middle" >Tongue</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >+Keratin, EMA, CEA, NSE</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >DUC at 2 mths</td><td align="center" valign="middle" >Yoshida, et al. 1995 [<xref ref-type="bibr" rid="scirp.83133-ref12">12</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >46/F</td><td align="center" valign="middle" >Mandible</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >TC</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+CGA, NSE</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 24 mths</td><td align="center" valign="middle" >Coleman, et al. 1996 [<xref ref-type="bibr" rid="scirp.83133-ref13">13</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >49/M</td><td align="center" valign="middle" >Floor of mouth</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Medium to large</td><td align="center" valign="middle" >+CGA, SYP, CT, LMW-CK</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >DOD at 10 days</td><td align="center" valign="middle" >Baker, et al. 1999 [<xref ref-type="bibr" rid="scirp.83133-ref14">14</xref>]</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >59/M</td><td align="center" valign="middle" >Gingiva</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC and SCC</td><td align="center" valign="middle" >Large</td><td align="center" valign="middle" >+CGA, CD56</td><td align="center" valign="middle" >+CAM5.2</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >Oku, et al, 2002 [<xref ref-type="bibr" rid="scirp.83133-ref8">8</xref>]</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >68/M</td><td align="center" valign="middle" >Gingiva</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >AC</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+CGA,SYP, NSE, CAM5.2, AE1/AE3</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >Abiko, et al. 2004 [<xref ref-type="bibr" rid="scirp.83133-ref15">15</xref>]</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >79/M</td><td align="center" valign="middle" >Tongue</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Large</td><td align="center" valign="middle" >+CD56, NSE, p16, p53, p63, 34βE12, CK5/6, CK19</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 18 mths</td><td align="center" valign="middle" >Kusafuka, et al. 2009 [<xref ref-type="bibr" rid="scirp.83133-ref16">16</xref>]</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >62/F</td><td align="center" valign="middle" >Gingiva</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC and SCC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >+CGA, SYP, CD56, NSE, K7, K19</td><td align="center" valign="middle" >+K5, K14, K15, K17, p63</td><td align="center" valign="middle" >NED at 23 mths</td><td align="center" valign="middle" >Mochizuki, et al. 2010 [<xref ref-type="bibr" rid="scirp.83133-ref7">7</xref>]</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >34/F</td><td align="center" valign="middle" >Retromolar</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Large</td><td align="center" valign="middle" >+CGA, CD56, CD57, S100P, Keratin, EMA</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >AWD at 9 mths</td><td align="center" valign="middle" >Krishnamurthy, et al. 2011 [<xref ref-type="bibr" rid="scirp.83133-ref17">17</xref>]</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >46/F</td><td align="center" valign="middle" >Retromolar</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >TC</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+CGA, SYP, NSE, AE1/AE3, CK7, p63, S100, Vimentin, CD57</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 11 mths</td><td align="center" valign="middle" >Yang, et al., 2011 [<xref ref-type="bibr" rid="scirp.83133-ref18">18</xref>]</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >57/M</td><td align="center" valign="middle" >Uvula</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >AC</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+SYP, EMA, AE1/AE2</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >DOD at 9 mths</td><td align="center" valign="middle" >Goldman, et al., 2012 [<xref ref-type="bibr" rid="scirp.83133-ref19">19</xref>]</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >25/F</td><td align="center" valign="middle" >Gingiva</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Medium to large</td><td align="center" valign="middle" >+SYP, NSE, S100</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 13 mths</td><td align="center" valign="middle" >Wu, et al. 2014 [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>]</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >38/F</td><td align="center" valign="middle" >Buccal mucosa</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >+SYP, EMA, AE1/AE3</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 8 mths</td><td align="center" valign="middle" >Wu, et al. 2014 [<xref ref-type="bibr" rid="scirp.83133-ref3">3</xref>]</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >73/M</td><td align="center" valign="middle" >Gingiva</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >NEC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >+CGA, SYP, NSE, AE1/AE3</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >NED at 14 mths</td><td align="center" valign="middle" >Zeng, et al. 2015 [<xref ref-type="bibr" rid="scirp.83133-ref4">4</xref>]</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >65/M</td><td align="center" valign="middle" >Floor of mouth</td><td align="center" valign="middle" >NA</td><td align="center" valign="middle" >AC and SCC</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+SYP, CD56</td><td align="center" valign="middle" >+34βE12, p63</td><td align="center" valign="middle" >AWRR at 6 mths</td><td align="center" valign="middle" >Yamagata, et al. 2016 [<xref ref-type="bibr" rid="scirp.83133-ref6">6</xref>]</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >59/M</td><td align="center" valign="middle" >Soft palate</td><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >NEC and SCC</td><td align="center" valign="middle" >Small</td><td align="center" valign="middle" >+CGA, SYP, CD56, p16</td><td align="center" valign="middle" >+34βE12, p63, p16</td><td align="center" valign="middle" >NED at 30 mths</td><td align="center" valign="middle" >Our case</td></tr></tbody></table></table-wrap><p>M, Male; F, Female; NA, Not available; TC, Typical carcinoid; AC, Atypical carcinoid; NEC, Neuroendocrine carcinoma; SCC, Squamous cell carcinoma; IHC, immunohistochemistry; EMA, Epithelial membrane antigen; CEA, Carcinoembryonic antigen; NSE, Neuron specific enolase; CGA, Chromogranin A; SYP, Synaptophysin; CK, Cytokeratin; LMW, Low molecular weight; CT, Calcitonin; K, Keratin; DOD, Died of disease; DUC, Died of unrelated cause; NED, No evidence of disease; AWD, Alive with disease; AWRR, Alive with recurrent relapses; mths, months.</p><p>with extensive mitotic activities. In the present case, the histomorphology of the SCC part was similar to that describe by El-Mofty et al. [<xref ref-type="bibr" rid="scirp.83133-ref25">25</xref>] . The NEC part of our case was comprised of small round to oval atypical cells with high mitotic activities, hyperchromatic molded nuclei, and a high nuclear-to-cytoplasmic ratio. Furthermore, in our case, the tumorcells of both components were diffuse and strongly positive for p16. Immunohistochemistry of this marker is considered to be a reliable surrogate marker of high-risk HPV infection when considering with the appropriate morphologies in oropharyngeal carcinomas [<xref ref-type="bibr" rid="scirp.83133-ref26">26</xref>] . Therefore, in our case, there was a possibility of HPV infection in both NEC and SCC components.</p><p>The prognosis of NEC of the oral cavity remains obscure. Variations in the location, size, extension, and differentiation of the primary tumor influence the prognosis [<xref ref-type="bibr" rid="scirp.83133-ref27">27</xref>] . For laryngeal NECs, the 5-year survival rates of the well, moderately, and poorly differentiated types are approximately 80%, 50%, and 15%, respectively [<xref ref-type="bibr" rid="scirp.83133-ref10">10</xref>] . In our case, there was no evidence of disease at 30 months after surgery.</p><p>To the best of our knowledge, the present case is the first of a composite tumor consisting of NEC and SCC of the soft palate. Further studies are needed to elucidate the histogenesis, precise treatment, and prognosis of oral NEC. Hence, more cases and future studies are needed to clarify the pathophysiology of NEC combined with SCC.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In summary, we have presented a rare case of primary NEC combined with SCC of the soft palate. The final diagnosis was concluded through the combination of morphological and immunohistochemical results. More cases of this composite tumor in the oral region are required to clarify their pathophysiology.</p></sec><sec id="s6"><title>Declarations</title><p>The study protocol was approved by the Ethics Committee of Kyushu Dental University Hospital and written informed consent was obtained from the patient.</p></sec><sec id="s7"><title>Competing Interests</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s8"><title>Cite this paper</title><p>Udompatanakorn, C., Yada, N., Ishikawa, A., Miyamoto, I., Sato, Y. and Matsuo, K. (2018) Primary Neuroendocrine Carcinoma Combined with Squamous Cell Carcinoma of the Soft Palate: A Case Report and Review of Literature. Open Journal of Stomatology, 8, 90-99. https://doi.org/10.4236/ojst.2018.83008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.83133-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mills, S.E. (2002) Neuroectodermal Neoplasms of the Head and Neck with Emphasis on Neuroendocrine Carcinomas. Modern Pathology, 15, 264-278. https://doi.org/10.1038/modpathol.3880522</mixed-citation></ref><ref id="scirp.83133-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Perez-Ordonez, B., Bishop, J.A., Gnepp, D.R., Hunt, J.L. and Thompson, L.D.R. (2017) Neuroendocrine Tumours. In: El-Naggar, A.K., Chan, J.K.C., Grandis, J.R., Takata, T. and Slootweg, P.J., Eds., WHO Classification of Head and Neck Tumours, 4th Edition, IARC, Lyon, 95-98.</mixed-citation></ref><ref id="scirp.83133-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Wu, B.Z., Gao, Y. and Yi, B. (2014) Primary Neuroendocrine Carcinoma in Oral Cavity: Two Case Reports and Review of the Literature. Journal of Oral and Maxillofacial Surgery, 72, 633-644. https://doi.org/10.1016/j.joms.2013.08.020</mixed-citation></ref><ref id="scirp.83133-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Zeng, M., Yang, S.D., Zhang, J.L. and Chen, X.M. (2015) Primary Small Cell Neuroendocrine Carcinoma of the Oral Cavity: A Case Report and Review of the Literature. Oncology Letters, 10, 887-890. https://doi.org/10.3892/ol.2015.3298</mixed-citation></ref><ref id="scirp.83133-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Davies-Husband, C.R., Montgomery, P., Premachandra, D. and Hellquist, H. (2010) Primary, Combined, Atypical Carcinoid and Squamous Cell Carcinoma of the Larynx: A New Variety of Composite Tumour. The Journal of Laryngology &amp; Otology, 124, 226-229. https://doi.org/10.1017/S0022215109991228</mixed-citation></ref><ref id="scirp.83133-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yamagata, K., Terada, K., Uchida, F., Kanno, N., Hasegawa, S., Yanagawa, T. and Bukawa, H. (2016) A Case of Primary Combined Squamous Cell Carcinoma with Neuroendocrine (Atypical Carcinoid) Tumor in the Floor of the Mouth. Case Reports in Dentistry, 2016, Article ID: 7532805. https://doi.org/10.1155/2016/7532805</mixed-citation></ref><ref id="scirp.83133-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mochizuki, Y., Omura, K., Sakamoto, K., Nakanishi, S., Satoh, K., Murakawa, E. and Yamaguchi, A. (2010) A Case of Primary Combined Neuroendocrine Carcinoma with Squamous Cell Carcinoma in The Upper Gingiva. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 109, e34-e39. https://doi.org/10.1016/j.tripleo.2009.12.018</mixed-citation></ref><ref id="scirp.83133-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Oku, N., Umeda, M., Ri, S., Takenono, I., Ishii, J. and Komori, T. (2002) A Case of Combined Large Cell Neuroendocrine Carcinoma of the Lower Gingiva with Focal Differentiation to Squamous Cell Carcinoma. Japanese Journal of Oral and Maxillofacial Surgery, 48, 12-15. https://doi.org/10.5794/jjoms.48.12</mixed-citation></ref><ref id="scirp.83133-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Mahomed, F. (2010) Neuroendocrine Cells and Associated Malignancies of the Oral Mucosa: A Review. Journal of Oral Pathology &amp; Medicine, 39, 121-127. https://doi.org/10.1111/j.1600-0714.2009.00834.x</mixed-citation></ref><ref id="scirp.83133-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Van Der Laan, T.P., Plaat, B.E., Van Der Laan, B.F. and Halmos, G.B. (2015) Clinical Recommendations on Treatment of Neuroendocrine Carcinoma of the Larynx: A Meta-Analysis of 436 Reported Cases. Head &amp; Neck, 37, 707-715. https://doi.org/10.1002/hed.23666</mixed-citation></ref><ref id="scirp.83133-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Benning, T.L., Vollmer, R.T., Crain, B.J. and Shelburne, J.D. (1990) Neuroendocrine Carcinoma of the Oral Cavity. Modern Pathology, 3, 631-634.</mixed-citation></ref><ref id="scirp.83133-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Yoshida, H., Onizawa, K. and Hirohata, H. (1995) Neuroendocrine Carcinoma of the Tongue: Report of a Case. Journal of Oral and Maxillofacial Surgery, 53, 823-827. https://doi.org/10.1016/0278-2391(95)90342-9</mixed-citation></ref><ref id="scirp.83133-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Coleman, H., Kennedy, M., Altini, M., Crooks, J. and Tsakiris, P. (1996) Neuroendocrine (Carcinoid) Tumor of the Mandible: A Case Report and Review of the Literature. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontology, 81, 74-78. https://doi.org/10.1016/S1079-2104(96)80152-1</mixed-citation></ref><ref id="scirp.83133-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Baker, P. and Alguacil-Garcia, A. (1999) Moderately Differentiated Neuroendocrine Carcinoma in the Floor of the Mouth: A Case Report. Journal of Oral and Maxillofacial Surgery, 57, 1143-1147. https://doi.org/10.1016/S0278-2391(99)90344-0</mixed-citation></ref><ref id="scirp.83133-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Abiko, Y., Ogawa, I., Hattori, Y., Kusano, K., Nishimura, M., Ohuchi, T., Abe, U., Shibata, T., Matsuda, S., Takada, T. and Kaku, T. (2004) Atypical Carcinoid (Neuroendocrine Carcinoma) of the Gingiva: Counter Part of a Laryngeal Tumor. Pathology International, 54, 97-100. https://doi.org/10.1111/j.1440-1827.2004.01598.x</mixed-citation></ref><ref id="scirp.83133-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kusafuka, K., Asano, R., Kamijo, T., Iida, Y., Onisuka, T., Kameya, T. and Nakajima, T. (2009) Large Cell Neuroendocrine Carcinoma of the Tongue Base: Case Report of an Unusual Location with Immunohistochemical Analysis. International Journal of Oral &amp; Maxillofacial Surgery, 38, 296-299. https://doi.org/10.1016/j.ijom.2008.12.012</mixed-citation></ref><ref id="scirp.83133-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Krishnamurthy, A., Vaidhyanathan, A. and Majhi, U. (2011) Large Cell Neuroendocrine Carcinoma of the Retromolar Trigone. Journal of Cancer Research and Therapeutics, 7, 343-346. https://doi.org/10.4103/0973-1482.87002</mixed-citation></ref><ref id="scirp.83133-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yang, S., Chen, S., Chen, X. and Long, X. (2011) Primary Typical Carcinoid Tumour in the Retromolar Region with Prominent Squamous Differentiation: A Case Report. International Journal of Oral and Maxillofacial Surgery, 40, 991-994. https://doi.org/10.1016/j.ijom.2011.03.008</mixed-citation></ref><ref id="scirp.83133-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Goldman, N.C. and Barnes, R.J. (2012) Atypical Carcinoid (Moderately Differentiated Neuroendocrine Carcinoma) of the Uvula. Ear, Nose &amp; Throat Journal, 91, 75-76.</mixed-citation></ref><ref id="scirp.83133-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Nisman, B., Heching, N., Biran, H., Barak, V. and Peretz, T. (2006) The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron Specific Enolase in Patients with Advanced Non-Small-Cell-Lung Cancer. Tumor Biology, 27, 8-16. https://doi.org/10.1159/000090151</mixed-citation></ref><ref id="scirp.83133-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ferlito, A., Devaney, K.O. and Rinaldo, A. (2006) Neuroendocrine Neoplasms of the Larynx: Advances in Identification, Understanding and Management. Oral Oncology, 42, 770-788. https://doi.org/10.1016/j.oraloncology.2006.01.002</mixed-citation></ref><ref id="scirp.83133-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Posligua, L., Malpica, A., Liu, J., Brown, J. and Deavers, M.T. (2008) Combined Large Cell Neuroendocrine Carcinoma and Papillary Serous Carcinoma of the Endometrium with Pagetoid Spread. Archives of Pathology &amp; Laboratory Medicine, 132, 1821-1824.</mixed-citation></ref><ref id="scirp.83133-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Franchi, A., Rocchetta, D., Palomba, A., Delgi Innocenti, D.R., Castiglione, F. and Spinelli, G. (2015) Primary Combined Neuroendocrine and Squamous Cell Carcinoma of the Maxillary Sinus: Report of a Case with Immunohistochemical and Molecular Characterization. Head and Neck Pathology, 9, 107-113. https://doi.org/10.1007/s12105-013-0513-5</mixed-citation></ref><ref id="scirp.83133-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Martinez-Madrigal, F., Baden, E., Casiraghi, O. and Micheau, C. (1991) Oral and Pharyngeal Adenosquamous Carcinoma. A Report of Four Cases with Immunohistochemical Studies. European Archives Oto-Rhino-Laryngology, 248, 255-258. https://doi.org/10.1007/BF00176748</mixed-citation></ref><ref id="scirp.83133-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">El-Mofty, S.K. and Patil, S. (2006) Human Papilloma (HPV)-Related Oropharyngeal Nonkeratinizing Squamous Cell Carcinoma: Characterization of Distinct Phenotype. Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontology, 101, 339-345. https://doi.org/10.1016/j.tripleo.2005.08.001</mixed-citation></ref><ref id="scirp.83133-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Lewis Jr., J.S. (2012) p16 Immunohistochemistry as a Standalone Test for Risk Stratification in Oropharyngeal Squamous Cell Carcinoma. Head and Neck Pathology, 6, S75-S82. https://doi.org/10.1007/s12105-012-0369-0</mixed-citation></ref><ref id="scirp.83133-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Pinchot, S.N., Holen, K., Sippel, R.S. and Chen, H. (2008) Carcinoid Tumors. Oncologist, 13, 1255-1269. https://doi.org/10.1634/theoncologist.2008-0207</mixed-citation></ref></ref-list></back></article>